Enrollment underway at Mackay Base Hospital in Queensland, Australia; additional sites in final activation stages SARASOTA, Fla., April 20, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: ...

Second candidate from Tenvie’s product engine to enter clinical development Phase 1 first-in-human study to evaluate single and multiple ascending doses of TNV108 in healthy volunteers Preliminary ...

SAN DIEGO, April 20, 2026 /PRNewswire/ -- Abogen, a clinical-stage biotechnology company focused on RNA innovation, today announced preliminary clinical results from the first-in-human (FIH) study of ...

Brain fog is a common side effect of chemotherapy for cancer, with the toxic drug cocktails affecting attention, memory and ...

An FDA review of records in the U.S. clinical trials database shows that results have not been reported for 30% of clinical ...

Masitinib is an experimental oral therapy for ALS that's aimed at slowing disease progression. AB Science secured insurance ...

Stellate Ganglion Blockade (SGB) is increasingly recognized as a significant therapeutic modality in the treatment of various clinical disorders, including regional pain syndromes, autonomic ...

Unanticipated use of acute care soon after starting a clinical trial may predict mortality risk among older adults with metastatic cancer, according to study results.An analysis of data from several r ...

Clinical trial quality starts with culture. Learn how one company’s ethical lapses led to bankruptcy—and how the ASPIRE ...

A £6.9m clinical trial programme that aims to improve brain cancer treatment for patients in Yorkshire has been launched by a ...